Management of anti-EGFR-targeting monoclonal antibody-induced hypomagnesemia.
Fakih
Marwan
M
Roswell Park Cancer Institute, Buffalo, New York 14263, USA. marwan.fakih@roswellpark.org
D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents / Q000009:adverse effects*; D000068818:Cetuximab; D066246:ErbB Receptors / Q000276:immunology*; D006801:Humans; D008275:Magnesium Deficiency / Q000209:etiology*; D000077544:Panitumumab
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents; D000077544:Panitumumab; D066246:ErbB Receptors; D000068818:Cetuximab